A fresh face: Avenir, formerly CURE, embraces rebrand
In a continued effort to rebuild its image and set a new standard for the company, CURE Pharmaceutical has rebranded to Avenir Wellness, the company announced on Jan. 17. Formerly located in Oxnard, Avenir’s new headquarters is now in Sherman Oaks, as the company’s decision to rebrand is also the result of its selling of Read More →
Semtech closes $1.2B acquisition, could see big bounce back in 2023
Camarillo-based Semtech Corp. closed its acquisition of Sierra Wireless, it announced on Jan. 12, setting the stage for the semiconductor company to reach new heights. Semtech, which specializes in the Internet of Things applications, concluded its months process with an all-cash transaction worth about $1.2 billion, making it the largest acquisition in the company’s history. Read More →
Beni leads charge for women-founded companies on Central Coast
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen sees slight stock climb behind regulatory wins
Goleta-based Inogen saw its stock climb about 3% after the company achieved regulatory milestones in the European Union and the United States to support its products and shared its preliminary fourth quarter and full-year revenue results on Jan. 10. Inogen, a maker of portable oxygen containers, received European Medical Device Regulation certification from the British Read More →
Westlake Village Biopartners’ backed Acelyrin makes first acquisition
Acelyrin, a Los Angeles-based biotechnology company, announced its first acquisition of ValenzaBio, a privately held company developing therapies for autoimmune and inflammatory diseases, in an all-stock transaction, the company said Jan. 5. With the acquisition, Acelyrin gains multiple clinical and pre-clinical development programs to its robust immunology pipeline, which is led by izokibep, a small Read More →
Arcutis approves equity grants
Westlake Village-based Arcutis Biotherapeutics announced the grant of an aggregate of 17,050 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 33,550 shares of Arcutis’ common stock to five newly hired employees. The stock options have a ten-year term and an exercise price of $14.77 per share, equal to Read More →
Mercado: Central Coast’s unique technology landscape will continue thrive in 2023
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
